• Globe Newswire

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

Globenewswire -

• Globe Newswire

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC

Globenewswire -

• Globe Newswire

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Globenewswire -

• Globe Newswire

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules

• Globe Newswire

Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva